Amedeo's Top 20

Amedeo Smart

Independent Medical Education

21 September 2015

Multidisciplinary Journal Club

  1. Bochkov YA, Watters K, Ashraf S, Griggs TF, et al.
    Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication.
    Proc Natl Acad Sci U S A 2015.

  1. Appiah GD, Blanton L, D'Mello T, Kniss K, et al.
    Influenza Activity - United States, 2014-15 Season and Composition of the 2015-16 Influenza Vaccine.
    MMWR Morb Mortal Wkly Rep 2015;64:583-590.

  2. Mol BW, Roberts CT, Thangaratinam S, Magee LA, et al.
    Lancet 2015.

  3. Tiacci E, Park JH, De Carolis L, Chung SS, et al.
    Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.
    N Engl J Med 2015.

  4. Adler RA, Fuleihan GE, Bauer DC, Camacho PM, et al.
    Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
    J Bone Miner Res 2015.

  1. Xu L , Bao L, Deng W, Dong L, et al.
    The Novel Avian-Origin Human A (H7N9) Influenza Virus Could be Transmitted between Ferrets via Respiratory Droplets.
    J Infect Dis 2013.

  2. Schuind A, Segall N, Drame M, Innis BL, et al.
    Immunogenicity and safety of an EB66 cell-culture-derived A/Indonesia/5/2005 (H5N1)-AS03-adjuvanted influenza vaccine: Phase-I randomized trial.
    J Infect Dis 2015.

  3. Watson SJ, Langat P, Reid SM, Lam TT, et al.
    Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013.
    J Virol 2015.

  4. Davis JS, Sud A, O'Sullivan MV, Robinson JO, et al.
    Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: A pilot multicenter randomized controlled trial.
    Clin Infect Dis 2015.

  5. Herrmann M, Sullivan DR, Veillard A, McCorquodale T, et al.
    Serum 25-Hydroxy Vitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes.
    Diabetes Care 2014.

  1. Yang ML , Chen YH, Wang SW, Huang YJ, et al.
    Galectin-1 Binds to Influenza Virus and Ameliorates Influenza Pathogenesis.
    J Virol 2011.

  2. Kalra L, Irshad S, Hodsoll J, Simpson M, et al.
    Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.
    Lancet 2015.

  3. Ylosmaki L, Schmotz C, Ylosmaki E, Saksela K, et al.
    Reorganization of the host cell Crk(L)-PI3 kinase signaling complex by the influenza A virus NS1 protein.
    Virology 2015;484:146-152.

  4. Bonificio A, Ghartey-Tagoe E, Gallorini S, Baudner B, et al.
    Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
    Vaccine 2015.

  5. Rudin CM, Ismaila N, Hann CL, Malhotra N, et al.
    Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.
    J Clin Oncol 2015.

  1. Girard MP , Katz JM, Pervikov Y, Hombach J, et al.
    Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Vaccine 2011.

  2. Nanda RH, Liu Y, Gillespie TW, Mikell JL, et al.
    Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
    Cancer 2015.

  3. Durkee BY, Qian Y, Pollom EL, King MT, et al.
    Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
    J Clin Oncol 2015.

  4. Srinath A, Young E, Szigethy E.
    Pain Management in Patients with Inflammatory Bowel Disease: Translational Approaches from Bench to Bedside.
    Inflamm Bowel Dis 2014.

  5. Engstrom T, Kelbaek H, Helqvist S, Hofsten DE, et al.
    Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial.
    Lancet 2015;386:665-71.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016